Quarterly Results Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
646.85
613.16
585.16
558.57
553.54
525.58
494.63
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
646.85
613.16
585.16
558.57
553.54
525.58
494.63
Raw Material Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Purchase of Finished goods
181.22
166.33
154.08
151.76
148.64
135.74
124.65
(Increase) / Decrease In Stocks
-4.07
-4.46
-0.05
-2.65
-4.41
-2.51
-1.92
Employee Cost
94.18
97.77
92.81
90.24
85.27
85.16
76.85
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
136.60
133.02
129.20
122.53
117.89
112.05
105.61
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
115.61
112.71
103.40
108.31
103.88
104.23
97.41
Total Expenditure (Excl Depreciation)
523.54
505.37
479.44
470.19
451.27
434.67
402.60
Operating Profit (PBDIT) excl Other Income
123.31
107.79
105.72
88.38
102.27
90.91
92.03
Other Income
2.62
6.83
10.23
4.64
11.13
8.81
5.05
Operating Profit (PBDIT)
125.93
114.62
115.95
93.02
113.40
99.72
97.08
Interest
43.62
45.47
44.17
40.70
35.98
33.71
26.84
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
3.90
Gross Profit (PBDT)
82.31
69.15
71.78
52.32
77.42
66.01
74.14
Depreciation
62.80
57.91
58.07
56.52
49.74
47.01
45.98
Profit Before Tax
19.82
11.92
13.62
-3.30
27.65
18.99
28.22
Tax
-0.84
5.94
6.85
-11.05
6.97
5.36
4.76
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
20.35
5.30
6.86
6.85
20.71
13.64
23.40
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
20.35
5.30
6.86
6.85
20.71
13.64
23.40
Share in Profit of Associates
0.31
0.68
-0.09
0.90
-0.03
-0.01
0.06
Minority Interest
4.39
1.23
-0.59
0.77
2.69
1.55
2.20
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
16.27
4.75
7.36
6.98
17.99
12.08
21.26
Equity Capital
141.00
139.42
139.42
139.40
139.39
139.35
139.29
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
79.62
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
1.15
0.34
0.53
0.5
1.29
0.87
1.53
Diluted Earnings per share
1.16
0.34
0.52
0.49
1.28
0.86
1.51
Operating Profit Margin (Excl OI)
19.11%
17.62%
18.12%
15.85%
18.51%
17.33%
18.66%
Gross Profit Margin
12.76%
11.3%
12.3%
9.38%
14.01%
12.58%
15.03%
PAT Margin
3.2%
0.98%
1.16%
1.39%
3.74%
2.6%
4.76%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2025 is 16.86% vs 13.68% in Sep 2024
Consolidate Net Profit
YoY Growth in quarter ended Sep 2025 is -9.56% vs 32.57% in Sep 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2025 is 20.57% vs 20.84% in Sep 2024
Interest
YoY Growth in quarter ended Sep 2025 is 21.23% vs 33.80% in Sep 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024
Compare Quarterly Results Of Health.Global With
Figures in Cr
Consolidate Quarterly Results
Change(INR)
Change(%)
Net Sales
646.85
444.80
202.05
45.42%
Other Operating Income
0.00
0.00
0.00
Total Operating income
646.85
444.80
202.05
45.42%
Raw Material Cost
0.00
62.21
-62.21
-100.00%
Purchase of Finished goods
181.22
0.00
181.22
(Increase) / Decrease In Stocks
-4.07
0.00
-4.07
Employee Cost
94.18
58.78
35.40
60.22%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
136.60
0.00
136.60
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
115.61
174.95
-59.34
-33.92%
Total Expenditure (Excl Depreciation)
523.54
295.94
227.60
76.91%
Operating Profit (PBDIT) excl Other Income
123.31
148.86
-25.55
-17.16%
Other Income
2.62
8.20
-5.58
-68.05%
Operating Profit (PBDIT)
125.93
157.06
-31.13
-19.82%
Interest
43.62
18.85
24.77
131.41%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
82.31
138.21
-55.90
-40.45%
Depreciation
62.80
35.84
26.96
75.22%
Profit Before Tax
19.82
102.37
-82.55
-80.64%
Tax
-0.84
26.75
-27.59
-103.14%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
20.35
75.62
-55.27
-73.09%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
20.35
75.62
-55.27
-73.09%
Share in Profit of Associates
0.31
0.00
0.31
Minority Interest
4.39
0.37
4.02
1,086.49%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
16.27
75.25
-58.98
-78.38%
Equity Capital
141.00
101.56
39.44
38.83%
Face Value
10.00
10.00
0.00
Reserves
79.62
0.00
79.62
Earnings per share (EPS)
1.15
7.41
-6.26
-84.48%
Diluted Earnings per share
1.16
7.41
-6.25
-84.35%
Operating Profit Margin (Excl OI)
19.11%
33.47%
0.00
-14.36%
Gross Profit Margin
12.76%
31.07%
0.00
-18.31%
PAT Margin
3.20%
17.00%
0.00
-13.80%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 646.85 Cr
in Sep 2025Figures in Cr
QoQ Growth in quarter ended Sep 2025 is 5.49% vs 4.79% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 16.86% vs 13.68% in Sep 2024
Quarterly - Consolidate Net Profit
Consolidate Net Profit 16.27 Cr
in Sep 2025Figures in Cr
QoQ Growth in quarter ended Sep 2025 is 242.53% vs -35.46% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -9.56% vs 32.57% in Sep 2024
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 123.31 Cr
in Sep 2025Figures in Cr
QoQ Growth in quarter ended Sep 2025 is 14.40% vs 1.96% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 20.57% vs 20.84% in Sep 2024
Quarterly - Interest
Interest 43.62 Cr
in Sep 2025Figures in Cr
QoQ Growth in quarter ended Sep 2025 is -4.07% vs 2.94% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 21.23% vs 33.80% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.11%
in Sep 2025Figures in %
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
